Company profile
Solana Company
NASDAQ: HSDT · Healthcare · Medical - Devices
#932 of 1,422 Healthcare companies by revenue61st-percentile growth
EA Score
49DFH 56DQ 37GM 52SS 53
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, Altman-Z · ↓ operating margin, net margin
Methodology →Revenue TTM
$9.6M
Rev growth YoY (TTM)
+2109.4%
Net income (FY)
-$40.9M
Employees
21
as of 2026-08-18
Market cap
$102.2M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$548.0k$548.0k2025
Net income-$40.9M-$40.9M2025
Operating income-$243.8M-$243.8M2025
Total assets$303.9M$303.9M2025
Liabilities$3.0M$3.0M2025
Equity$300.9M$300.9M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product77%
Product and Service, Other23%
By geography
UNITED STATES55%
CANADA45%
The read
What is Solana Company’s revenue?
Solana Company booked $548.0k in FY2025 revenue, growing 15% year over year — faster than most Healthcare companies we track, at a -7461.7% net margin.
Peers · Healthcare
Viropro Inc.——VYNE Therapeutics Inc.38DTrevena, Inc.——Cardax, Inc.——Lipella Pharmaceuticals Inc.——Sibannac, Inc.——Neighbors
Schuylkill →Key facts
CEODane Carl Andreeff
SectorHealthcare
IndustryMedical - Devices
HeadquartersNewtown, PA
ExchangeNASDAQ: HSDT
Employees21
IPO date2014-06-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.